{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67105af848726944170ab1fe/6ae9933bf5930510a0c835e8?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Ryan Beal: Getting Under Cancer's Skin","description":"<p>Dyve Biosciences is developing a technology to deliver drugs through the skin that conventional transdermal approaches cannot accommodate. Its lead oncology program, DV800, targets tumor acidity, a longstanding therapeutic challenge. In this episode of <em>Behind the Breakthroughs</em>, CEO Ryan Beal, MD, discusses the technology, its potential in cancer treatment, and how his own cancer experience reshaped his approach to drug development.</p><p><br></p><p>Produced and hosted by Jonathan D. Grinstein, PhD</p><p>Audio mixed and mastered by Erick Ziegler</p><p>Brought to you by Inside Precision Medicine (SAGE Publishing)</p>","author_name":"Inside Precision Medicine"}